Medicine

The NCAA Committee on Competitive Safeguards and Medical Aspects of Sports (CMAS) has recommended the removal of cannabis from its list of banned substances for all three collegiate divisions.

Texas Agricultural Commissioner Sid Miller (R) said that he believes if medical cannabis reforms were to get a vote in the state legislature, they would be supported by “70% to 80%” of lawmakers because “we have such good science on it.”

Officials on the Ohio State Medical Board last week added irritable bowel syndrome (IBS) as a qualifying condition to the state’s medical cannabis program.

A recent study published in Clinical Therapeutics found that 91% of military veterans who use medical cannabis said it has improved their quality of life.

The Ukraine Parliament gave initial approval this week to a medical cannabis legalization proposal. The law still could see additional amendments and must pass a second reading before heading to President Volodymyr Zelensky for his signature.

The Minnesota Department of Health has added irritable bowel syndrome (IBS) and obsessive-compulsive disorder (OCD) to the list of qualifying conditions for accessing the state medical cannabis program.

The Pennsylvania Senate Law & Justice Committee advanced a proposal that would let physicians certify patients for the state’s medical cannabis program for any condition they deem appropriate.

A Washington D.C. judge ruled this week that a medical cannabis patient who smokes in his apartment must stop following a neighbor’s complaint that the odor caused a nuisance in her apartment.

Weill Cornell Medicine researchers have received a five-year, $11.6 million grant from the National Institute on Drug Abuse to investigate the effects of cannabis on the brains of people who are living with HIV.

The New Mexico Department of Health has added insomnia to the state’s medical cannabis qualifying conditions list; patients with insomnia will be allowed to enroll starting June 1.

Oregon regulators have granted the state’s first psychedelic medicine treatment center license to Epic Healing Eugene, which plans to start serving patients later this month.

Charlotte’s Web Holdings Inc. announced it is partnering with a British American Tobacco subsidiary and AJNA BioSciences to pursue an FDA-approved, full-spectrum hemp extract botanical drug.

A recent study found the psychedelic DMT could improve symptoms of depression when used alongside therapy.

A Pennsylvania appeals court ruled last week that the state’s medical cannabis law does not prohibit health insurance providers from reimbursing workers’ medical cannabis treatment costs for work-related injuries.

Medical cannabis use doubled among Americans from 2013-2020, according to a new study.

The Yale School of Medicine in Connecticut last month announced its upcoming Center for the Science of Cannabis and Cannabinoids.

The American Society of Regional Anesthesia and Pain Medicine (ASRA Pain Medicine) released guidelines calling for all patients to be screened for cannabis use before surgery, citing concerns that regular cannabis consumers can experience more post-op pain and nausea.

Cannabis researchers published more than 4,300 studies investigating the effects and therapeutic benefits of cannabis this year, more than any other year.

Police in Hays, Kansas recently raided the hospital room of a terminally ill cancer patient, confiscating a THC-infused edible paste and vaping device said to contain cannabinoids. The patient was given a ticket and court summons but law enforcement later dropped the charges.

A judge in Georgia has halted the production of medical cannabis following legal protests against the process that awarded the two licenses.

Japan’s government is debating legalizing cannabis medicines, a historic change in Japan’s zero-tolerance drug laws.

Multiple Oregon municipalities are planning to put psilocybin therapy bans on November election ballots after state voters opted to legalize the treatment in 2020.

Students in Worcester County Public Schools in Maryland will now be able to access their medical cannabis during school hours.

The global medical cannabis industry is predicted to reach a value of $24.86 billion by 2027, according to a new report.